REPONEX PHARMACEUTICALS A/S: Financial statements 2014
CVR: 30082346
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
REPONEX PHARMACEUTICALS A/S (CVR 30082346) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 1 and a net result of DKK -682,835 compared with DKK 149,866 the year before. The profit margin was -68,283,500%. Equity in the 2014 report amounted to DKK 1,469,188. The solvency ratio was 47.6%.
- Revenue
- DKK 1
- Gross Profit
- DKK -34,135
- Profit/Loss
- DKK -682,835
- Equity
- DKK 1,469,188
- Total Assets
- DKK 3,084,569
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 1 | -34 t. | -683 t. | 1.5 mio. | - |
| 2013 | - | - | 150 t. | 230 t. | - |
| 2012 | - | - | -18 t. | 80 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
On November 12, 2014, the company changed its name from TRIFOILIUM ApS to REPONEX PHARMACEUTICALS ApS.
REPONEX PHARMACEUTICALS A/S has published its annual report for 2013. The net result was DKK 149,866.
About REPONEX PHARMACEUTICALS A/S
REPONEX PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPONEX PHARMACEUTICALS ApS and TRIFOILIUM ApS. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Troels Peter Troelsen and Charlotte Pahl. The company is owned by Pharma Equity Group A/S. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -6,570,000 compared with DKK -11,943,000 the year before. Equity in the 2025 report amounted to DKK 4,645,000.